SOPHiA GENETICS and Strand Life Sciences announce new strategic partnership

04th April, 2024

Companies will join forces to advance the use of precision medicine on a global scale

image credits: shutterstock

image credits: shutterstock

SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, has announced a strategic partnership with Bengaluru-based Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel the use of precision medicine globally. 

The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics technologies, cutting-edge bioinformatics services and innovative diagnostics solutions.

Through the broad-ranging collaboration between SOPHiA GENETICS and Strand, the two companies will use their bioinformatics expertise to expand the ability to accurately analyse key healthcare data and facilitate the use of data-driven decision-making globally.

SOPHiA GENETICS will provide support via the decentralised  SOPHiA DDM™ Platform and Strand via its curated variant databases and bioinformatics solutions expertise, and the companies will collaborate on strategic test co-development, among other initiatives, that will look to improve health outcomes in India and globally.

The SOPHiA DDM™ Platform is designed to compute a wide array of genomic variants and continually hone machine learning algorithms. With their sophisticated technologies and bioinformatics expertise, SOPHiA GENETICS and Strand will jointly deepen their value propositions.

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer